Local Institution

Leeds, Yorkshire LS9 7TF

0 studies enrolling now · 5 studies all time

What they study most

Endometrial Cancer, Hepato Cellular Carcinoma (HCC), High Risk Stage III Melanoma, Hodgkin Disease, Rheumatoid Arthritis

Studies at this site

• A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment — Completed
• Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma — Completed
• A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer — Stopped early
• First Line Hepato Cellular Carcinoma (HCC) — Completed
• Abatacept With Methotrexate- Phase IIB — Completed